Disseminated Tumor Cells Persist in the Bone Marrow of Breast Cancer Patients Through Sustained Activation of the Unfolded Protein Response
Overview
Authors
Affiliations
Disseminated tumor cells (DTC), which share mesenchymal and epithelial properties, are considered to be metastasis-initiating cells in breast cancer. However, the mechanisms supporting DTC survival are poorly understood. DTC extravasation into the bone marrow may be encouraged by low oxygen concentrations that trigger metabolic and molecular alterations contributing to DTC survival. Here, we investigated how the unfolded protein response (UPR), an important cytoprotective program induced by hypoxia, affects the behavior of stressed cancer cells. DTC cell lines established from the bone marrow of patients with breast cancer (BC-M1), lung cancer, (LC-M1), and prostate cancer (PC-E1) were subjected to hypoxic and hypoglycemic conditions. BC-M1 and LC-M1 exhibiting mesenchymal and epithelial properties adapted readily to hypoxia and glucose starvation. Upregulation of UPR proteins, such as the glucose-regulated protein Grp78, induced the formation of filamentous networks, resulting in proliferative advantages and sustained survival under total glucose deprivation. High Grp78 expression correlated with mesenchymal attributes of breast and lung cancer cells and with poor differentiation in clinical samples of primary breast and lung carcinomas. In DTCs isolated from bone marrow specimens from breast cancer patients, Grp78-positive stress granules were observed, consistent with the likelihood these cells were exposed to acute cell stress. Overall, our findings provide the first evidence that the UPR is activated in DTC in the bone marrow from cancer patients, warranting further study of this cell stress pathway as a predictive biomarker for recurrent metastatic disease.
Bartkowiak K, Mohammadi P, Nissen P, Werner S, Agorku D, Andreas A Sci Rep. 2025; 15(1):3913.
PMID: 39890941 PMC: 11785953. DOI: 10.1038/s41598-025-87122-4.
mTOR pathway occupies a central role in the emergence of latent cancer cells.
Aleksandrova K, Vorobev M, Suvorova I Cell Death Dis. 2024; 15(2):176.
PMID: 38418814 PMC: 10902345. DOI: 10.1038/s41419-024-06547-3.
Inhibition of protein translation under matrix-deprivation stress in breast cancer cells.
Warrier S, Srinivasan S, Chedere A, Rangarajan A Front Med (Lausanne). 2023; 10:1124514.
PMID: 37425300 PMC: 10324034. DOI: 10.3389/fmed.2023.1124514.
Cellular Dormancy in Cancer: Mechanisms and Potential Targeting Strategies.
Min H, Lee H Cancer Res Treat. 2023; 55(3):720-736.
PMID: 36960624 PMC: 10372609. DOI: 10.4143/crt.2023.468.
Proteome Coverage after Simultaneous Proteo-Metabolome Liquid-Liquid Extraction.
van Pijkeren A, Egger A, Hotze M, Zimmermann E, Kipura T, Grander J J Proteome Res. 2023; 22(3):951-966.
PMID: 36763818 PMC: 9990123. DOI: 10.1021/acs.jproteome.2c00758.